Enhancing UK Healthcare
At Lilly, we strongly believe in working closely with a variety of partners across the UK healthcare system to ensure patients get access to the most effective new medicines as fast as possible.
Whether it involves pioneering research into new therapies, working with patient organisations, or supporting clinical service delivery through patient-centred Joint Working projects, we are immensely proud of our work supporting the NHS.
Research collaborations are vital to our process of discovery. We are proud to be involved in research collaborations with academic institutions across the UK, working to discover and develop innovative, life-saving treatments.
We are one of the founding members of the Dementia Discovery Fund (DDF) which is focused entirely on discovering and developing novel therapies for dementia, including Alzheimer’s research. For us, participating in the DDF builds on our company’s own 30-plus year commitment to research in Alzheimer’s disease.
We are also supporting the Advanced Pain Discovery Platform (APDP), a consortium being led by the UKRI (Medical Research Council, Economic and Social Research Council and Biotechnology and Biological Sciences Research Council) and Versus Arthritis. Lilly is committed to working in partnership with the APDP to improve understanding of the complexity of pain, with the aim of helping people across the UK living with chronic and debilitating conditions.
Learn more about Lilly’s Scientific Partnering and areas of interest.
Collaborative Working Projects
Collaborative Working and Joint Working projects are a specific type of partnership between the NHS and the pharmaceutical industry, which aim to improve the efficiency and quality of the delivery of patient care.
We are proud to be involved in a number of projects across the UK, focused on improving healthcare for the patients we make medicines for including patients with diabetes, cancer and immunological conditions.
Our projects have delivered bespoke innovative solutions which are making a real difference to patients' lives, including advancing delivery of virtual dermatology consultations, and working to significantly reduce the time cancer patients spend in outpatient chemotherapy clinics.
Our Completed Collaborative Working Projects
Our Current Collaborative Working Projects
If you would like to learn more about our Collaborative Working Projects, please get in touch with our UK Public Affairs team.
Partnering with Patient Organisations
What is a Patient Organisation?
Patient organisations are non-profit organisations that represent and support the needs of patients and caregivers to improve the lives of people with a specific disease or medical condition.
Lilly’s Commitment to Patient Organisations
Lilly is passionate about fostering strong, genuine relationships with patient organisations. We are committed to working in partnership to better understand the experiences of patients and their loved ones, and support projects to improve their treatment and care.
To learn more about Payments to Patient Organisations and Payments to Healthcare Organisations, please view our Transparency Reports.